title: Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway.
abstract: OBJECTIVE
  Alterations in transforming growth factor-beta (TGF-beta) signaling occur early during malignant transformation of renal epithelial cells and are associated with loss of type III TGF-beta receptor (TbetaRIII) expression. We evaluated the role of TbetaRIII in mediation of apoptosis using in vitro cell culture and in vivo animal models of clear cell renal cell carcinoma.
  
  
  METHODS
  TbetaR3 expression was manipulated with adenoviral gene vector delivery system in vitro and in vivo. Induction of apoptosis and signaling through the Smad and mitogen-activated protein kinase (MAPK) pathways were examined at various time points after infection. To study viral oncolysis in vivo, human renal cell carcinoma cells were implanted s.c. in the flanks of nude mice and treated with intratumoral injections of adenovirus.
  
  
  RESULTS
  Restoring TbetaRIII expression in clear cell renal cell carcinoma resulted in a marked induction of apoptosis using in vitro cell culture and in vivo animal models. The expression of the cytoplasmic domain, but not the extracellular domain, of TbetaRIII mimicked the induction of apoptosis by full-length TbetaRIII in cell culture and the growth inhibition of tumors in athymic nude mice. TbetaRIII-associated apoptosis was not dependent on signaling through the canonical TGF-beta/Smad pathway but was mediated through p38 MAPK.
  
  
  CONCLUSIONS
  These findings indicate a novel mechanistic antitumor function for TbetaRIII and further support its role as an important tumor suppressor in clear cell renal cell carcinoma.
authors.affiliation: Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
authors.forename: Vitaly
authors.initials: V
authors.lastname: Margulis
authors.forename: Tapati
authors.initials: T
authors.lastname: Maity
authors.forename: Xiu-Ying
authors.initials: XY
authors.lastname: Zhang
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Cooper
authors.forename: John A
authors.initials: JA
authors.lastname: Copland
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Wood
mesh_terms: D000818:Animals; D017209:Apoptosis; D002292:Carcinoma, Renal Cell / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta; D048051:p38 Mitogen-Activated Protein Kinases
references.citation: J Clin Oncol. 2005 Mar 20;23(9):2078-93
references.pmid: 15774796
references.citation: Chem Res Toxicol. 2001 Jul;14(7):814-21
references.pmid: 11453727
references.citation: Science. 1999 Mar 26;283(5410):2080-2
references.pmid: 10092230
references.citation: Eur J Endocrinol. 2005 Feb;152(2):277-84
references.pmid: 15745937
references.citation: J Cell Biol. 1994 Feb;124(4):557-68
references.pmid: 8106553
references.citation: J Surg Oncol. 1985 Mar;28(3):237-44
references.pmid: 4038766
references.citation: Cell Cycle. 2005 Jan;4(1):118-20
references.pmid: 15611662
references.citation: Cancer Res. 2007 Jun 1;67(11):5231-8
references.pmid: 17522389
references.citation: Carcinogenesis. 2007 Dec;28(12):2491-500
references.pmid: 17768179
references.citation: EMBO J. 2002 Jul 15;21(14):3749-59
references.pmid: 12110587
references.citation: Cell. 1996 Oct 18;87(2):159-70
references.pmid: 8861899
references.citation: Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6302S-3S
references.pmid: 15448021
references.citation: Carcinogenesis. 2008 Mar;29(3):528-35
references.pmid: 18174241
references.citation: J Biol Chem. 1996 Aug 23;271(34):20608-16
references.pmid: 8702807
references.citation: J Biol Chem. 2001 Jul 6;276(27):24627-37
references.pmid: 11323414
references.citation: Oncogene. 2003 Sep 11;22(39):8053-62
references.pmid: 12970754
references.citation: J Clin Invest. 2007 Jan;117(1):206-17
references.pmid: 17160136
references.citation: Mol Cell. 2005 Jan 7;17(1):37-48
references.pmid: 15629715
references.citation: Am J Physiol Renal Physiol. 2004 Nov;287(5):F1049-58
references.pmid: 15226155
references.citation: J Cell Sci. 2005 Aug 15;118(Pt 16):3573-84
references.pmid: 16105881
references.citation: Science. 2003 Sep 5;301(5638):1394-7
references.pmid: 12958365
references.citation: J Biol Chem. 2001 Apr 27;276(17):14466-73
references.pmid: 11278290
references.citation: Cell. 1991 Nov 15;67(4):797-805
references.pmid: 1657407
references.citation: EMBO J. 1998 Jun 1;17(11):3091-100
references.pmid: 9606191
references.citation: Nat Genet. 2004 Apr;36(4):343-50
references.pmid: 14991053
references.citation: Cancer Res. 2007 Feb 1;67(3):1090-8
references.pmid: 17283142
references.citation: Adv Cancer Res. 2004;92:95-118
references.pmid: 15530558
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6686-91
references.pmid: 11390996
references.citation: Carcinogenesis. 2008 Feb;29(2):252-62
references.pmid: 17999987
references.citation: Cell Signal. 2006 Sep;18(9):1482-91
references.pmid: 16413747
references.citation: Cancer Cell. 2007 Feb;11(2):191-205
references.pmid: 17292829
references.citation: Cell. 1993 Jul 2;73(7):1435-44
references.pmid: 8391934
references.citation: Cell. 1991 Nov 15;67(4):785-95
references.pmid: 1657406
references.citation: J Biol Chem. 2007 Nov 2;282(44):32491-500
references.pmid: 17823118
references.citation: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references.pmid: 17237035
references.citation: Curr Opin Genet Dev. 2002 Feb;12(1):92-7
references.pmid: 11790561
references.citation: J Biol Chem. 2001 Oct 26;276(43):39608-17
references.pmid: 11546783